• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白磷酸酶2A(PP2A)失活在口腔癌中是常见事件,而FTY720使其重新激活显示出有前景的治疗潜力。

PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.

作者信息

Velmurugan Bharath K, Lee Chien-Hung, Chiang Shang-Lun, Hua Chun-Hung, Chen Mei-Chung, Lin Shu-Hui, Yeh Kun-Tu, Ko Ying-Chin

机构信息

Faculty of Applied Sciences, Ton Duc Thang University, Ho Chi Minh City, Vietnam.

Department of Public Health, College of Health Science, Kaohsiung Medical University, Kaohsuing, Taiwan.

出版信息

J Cell Physiol. 2018 Feb;233(2):1300-1311. doi: 10.1002/jcp.26001. Epub 2017 Jun 12.

DOI:10.1002/jcp.26001
PMID:28516459
Abstract

Protein phosphatase 2A (PP2A) is a tumor suppressor gene, that has been frequently deactivated in many types of cancer. However, its molecular and clinical relevance in oral squamous cell carcinoma (OSCC) remain unclear. Here we show that, PP2A deactivation is a common event in oral cancer cells and hyperphosphorylation in its tyrosine-307 (Y307) residue contributes to PP2A deactivation. PP2A restoration by FTY720 treatment reduced cell growth and decreased GSK-3β phosphorylation without significantly altering other PP2A targets. We further detected PP2A phosphorylation in 262 OSCC tissues. Increased expression of p-PP2A in the tumor tissues was significantly correlated with higher N2/N3-stage (aOR = 2.1, 95%CI: 1.2-3.8). Patients with high p-PP2A expression had lower overall survival rates than those with low expression. Hazard ratio analysis showed that, high p-PP2A expression was significantly associated with mortality density (aOR = 2.2, 95%CI: 1.2-4.0) and lower 10-year overall survival (p = 0.027) in lymph node metastasis. However, no interaction was observed between p-PP2A expression and lymph node metastasis. All our results suggest that PP2A is frequently deactivated in oral cancer and determines poor outcome, restoring its expression by FTY720 can be an alternative therapeutic approach in OSCC.

摘要

蛋白磷酸酶2A(PP2A)是一种肿瘤抑制基因,在多种癌症中经常被失活。然而,其在口腔鳞状细胞癌(OSCC)中的分子和临床相关性仍不清楚。在此我们表明,PP2A失活在口腔癌细胞中是常见事件,其酪氨酸307(Y307)残基的过度磷酸化导致PP2A失活。用FTY720处理恢复PP2A可降低细胞生长并减少糖原合成酶激酶-3β(GSK-3β)的磷酸化,而不会显著改变其他PP2A靶点。我们进一步检测了262例OSCC组织中的PP2A磷酸化情况。肿瘤组织中p-PP2A表达增加与更高的N2/N3分期显著相关(调整后比值比[aOR]=2.1,95%置信区间[CI]:1.2-3.8)。p-PP2A高表达患者的总生存率低于低表达患者。风险比分析表明,在淋巴结转移中,p-PP2A高表达与死亡密度显著相关(aOR=2.2,95%CI:1.2-4.0)且10年总生存率较低(P=0.027)。然而,未观察到p-PP2A表达与淋巴结转移之间存在相互作用。我们所有的结果表明,PP2A在口腔癌中经常失活并决定不良预后,通过FTY720恢复其表达可能是OSCC的一种替代治疗方法。

相似文献

1
PP2A deactivation is a common event in oral cancer and reactivation by FTY720 shows promising therapeutic potential.蛋白磷酸酶2A(PP2A)失活在口腔癌中是常见事件,而FTY720使其重新激活显示出有前景的治疗潜力。
J Cell Physiol. 2018 Feb;233(2):1300-1311. doi: 10.1002/jcp.26001. Epub 2017 Jun 12.
2
Synergic effect of OP449 and FTY720 on oral squamous cell carcinoma.OP449 与 FTY720 对口腔鳞状细胞癌的协同作用。
Eur J Pharmacol. 2020 Sep 5;882:173268. doi: 10.1016/j.ejphar.2020.173268. Epub 2020 Jun 20.
3
ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy.马来酸依那西普是口腔癌中的一种新型抗癌药物:对癌症治疗的意义。
Oncotarget. 2016 Mar 29;7(13):17162-81. doi: 10.18632/oncotarget.7751.
4
Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.肿瘤芽生的分子谱分析表明,TGFβ 介导的上皮-间充质转化是口腔鳞状细胞癌的治疗靶点。
J Pathol. 2015 Aug;236(4):505-16. doi: 10.1002/path.4550. Epub 2015 Jun 1.
5
Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.含锌指 AN1 结构域蛋白 4 是预测口腔鳞状细胞癌转移和预后不良的新型标志物。
J Clin Pathol. 2018 May;71(5):436-441. doi: 10.1136/jclinpath-2017-204770. Epub 2017 Oct 26.
6
Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human non-small cell lung cancer.蛋白磷酸酶2A(PP2A)抑制剂SET癌蛋白的过表达与人类非小细胞肺癌的肿瘤进展及不良预后相关。
Oncotarget. 2015 Jun 20;6(17):14913-25. doi: 10.18632/oncotarget.3818.
7
MERTK as a novel therapeutic target in head and neck cancer.MERTK作为头颈癌的新型治疗靶点。
Oncotarget. 2016 May 31;7(22):32678-94. doi: 10.18632/oncotarget.8724.
8
Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.Cdc7 表达增加是口腔鳞状细胞癌的一个标志物,Cdc7 的过表达导致对 DNA 损伤剂的耐药性。
Cancer Lett. 2013 Sep 1;337(2):218-25. doi: 10.1016/j.canlet.2013.05.008. Epub 2013 May 16.
9
Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.肿瘤浸润免疫细胞在口腔鳞状细胞癌中的预后意义
BMC Cancer. 2017 May 26;17(1):375. doi: 10.1186/s12885-017-3317-2.
10
Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.沉默JARID1B可抑制人类口腔癌的致癌性、干性并提高放射敏感性。
Cancer Lett. 2015 Nov 1;368(1):36-45. doi: 10.1016/j.canlet.2015.07.003. Epub 2015 Jul 13.

引用本文的文献

1
p21-Activated Kinase 1 (Pak1) as an Element in Functional and Dysfunctional Interplay Among the Myocardium, Adipose Tissue, and Pancreatic Beta Cells.p21激活激酶1(Pak1)作为心肌、脂肪组织和胰腺β细胞之间功能与功能失调相互作用的一个因素。
Compr Physiol. 2025 Apr;15(2):e70006. doi: 10.1002/cph4.70006.
2
A multiscale functional map of somatic mutations in cancer integrating protein structure and network topology.整合蛋白质结构和网络拓扑的癌症体细胞突变多尺度功能图谱。
Nat Commun. 2025 Jan 24;16(1):975. doi: 10.1038/s41467-024-54176-3.
3
Altering phosphorylation in cancer through PP2A modifiers.
通过PP2A修饰剂改变癌症中的磷酸化作用。
Cancer Cell Int. 2024 Jan 6;24(1):11. doi: 10.1186/s12935-023-03193-1.
4
TIPRL1 and its ATM-dependent phosphorylation promote radiotherapy resistance in head and neck cancer.TIPRL1 及其 ATM 依赖性磷酸化促进头颈部癌症的放疗抵抗。
Cell Oncol (Dordr). 2024 Jun;47(3):793-818. doi: 10.1007/s13402-023-00895-6. Epub 2023 Nov 16.
5
A multiscale functional map of somatic mutations in cancer integrating protein structure and network topology.整合蛋白质结构和网络拓扑的癌症体细胞突变多尺度功能图谱。
bioRxiv. 2024 Aug 8:2023.03.06.531441. doi: 10.1101/2023.03.06.531441.
6
Promising bioactive compounds from the marine environment and their potential effects on various diseases.来自海洋环境的有前景的生物活性化合物及其对各种疾病的潜在影响。
J Genet Eng Biotechnol. 2022 Jan 26;20(1):14. doi: 10.1186/s43141-021-00290-4.
7
Targeting Sphingolipids for Cancer Therapy.靶向鞘脂用于癌症治疗。
Front Oncol. 2021 Oct 19;11:745092. doi: 10.3389/fonc.2021.745092. eCollection 2021.
8
The Molecular 'Myc-anisms' Behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics.Myc 驱动的肿瘤发生背后的分子“机制”及相关的 Myc 靶向治疗。
Int J Mol Sci. 2020 Dec 13;21(24):9486. doi: 10.3390/ijms21249486.
9
Increased Expression of p-GSK3β Predicts Poor Survival in T -III/IV Stage OSCC Patients.p-GSK3β 的高表达预示着 T-III/IV 期口腔鳞状细胞癌患者的生存不良。
In Vivo. 2020 Jul-Aug;34(4):1805-1809. doi: 10.21873/invivo.11975.
10
Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration.蛋白磷酸酶 2A 作为炎症和神经退行性变的治疗靶点。
Pharmacol Ther. 2019 Sep;201:181-201. doi: 10.1016/j.pharmthera.2019.05.016. Epub 2019 Jun 1.